EP
PMI

Essential Partners’s Picard Medical PMI Stock Holding History

Essential Partners’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$161 Buy
20
+16
+400% +$340 ﹤0.01% 2674
2026
Q1 		$212 Buy
+4
New +$290 ﹤0.01% 2598

Other funds holding PMI

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Essential Partners's PMI Position: Q2 2026 in Review

Essential Partners increased its Picard Medical (PMI) stake by 400% in Q2 2026, buying an estimated $340 and bringing the position to 20 shares worth $161. The position accounts for ﹤0.01% of the portfolio, ranked #2674.

Essential Partners first reported a position in PMI in Q1 2026 and has held it in 2 quarters since. The position peaked at $212 in Q1 2026. 41 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • Essential Partners held 20 shares of Picard Medical worth $161 as of Q2 2026.
  • Essential Partners bought 16 Picard Medical shares in Q2 2026, an estimated $340.
  • Picard Medical made up ﹤0.01% of Essential Partners's portfolio in Q2 2026, its #2674 holding.
  • Essential Partners first reported a position in Picard Medical in Q1 2026 and has held it in 2 quarters since.
  • Essential Partners's Picard Medical position peaked at $212 in Q1 2026.
  • 41 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.